The Canadian cannabis producer missed revenue expectations but posted stronger margins as international sales surge.

Glass House attributed the solid results to cost cutting and lower production costs, along with increased same-store sales.

The U.S. cannabis market continues to be the largest in the world, but uncertainty around legalization and illicit market ...

The settlement could finally close the chapter on a five-year-old lawsuit alleging Tilray insiders secretly profited from ...

Republican Senators James Lankford of Oklahoma and Pete Ricketts of Nebraska filed a bill last week that would kill the 280e ...

The firm is betting big on harm-reduction technology, as the fentanyl crisis continues to drive demand for testing solutions.

The Democratic governor called for: Changing how marijuana is taxed, closing a “loophole” and transitioning to wholesale ...

MediPharm will keep its Ontario cannabis facility after Kensana missed deal conditions; company pivots to international focus.

Fourth-quarter 2024 sales in the state reached $457 million, up 17% year over year, after 11-12% growth in the first three ...

The vape firm went deeper in the red amid a 48% rise in costs, though its international expansion showed early signs of ...

A federal judge dismissed challenges - including from notorious litigators - to Rhode Island cannabis law, saying the cases ...

The craft soda maker finally found a new CEO and CFO, while securing additional financing to fuel its cannabis beverage ...